Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Covington
Moodys
Queensland Health
Boehringer Ingelheim
Merck
Cipla
Federal Trade Commission
Cerilliant
Accenture

Generated: August 19, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050794

« Back to Dashboard
NDA 050794 describes VIDAZA, which is a drug marketed by Celgene and is included in one NDA. It is available from two suppliers. Additional details are available on the VIDAZA profile page.

The generic ingredient in VIDAZA is azacitidine. There are thirteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the azacitidine profile page.

Summary for NDA: 050794

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 050794

Suppliers and Packaging for NDA: 050794

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VIDAZA
azacitidine
POWDER;IV (INFUSION), SUBCUTANEOUS 050794 NDA AUTHORIZED GENERIC Sandoz Inc 0781-3253 0781-3253-94 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (0781-3253-94)
VIDAZA
azacitidine
POWDER;IV (INFUSION), SUBCUTANEOUS 050794 NDA AUTHORIZED GENERIC Sandoz Inc 0781-9253 0781-9253-94 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (0781-9253-94)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;IV (INFUSION), SUBCUTANEOUSStrength100MG/VIAL
Approval Date:May 19, 2004TE:APRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Express Scripts
US Department of Justice
Fuji
Novartis
Queensland Health
Harvard Business School
Covington
Healthtrust
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot